Science Current Events | Science News | Brightsurf.com
 

Wild gorillas carriers of a SIV virus close to the AIDS virus

November 14, 2006
In 2005, 40.3 million people in the world, including 25.8 million in Sub-Saharan Africa, were living with HIV. The question of the origin of HIV-1, responsible for the AIDS pandemic, has been stimulating the scientific community for many years.

Some months ago, the team of Martine Peeters, director of research at IRD, and Eric Delaporte, director of the mixed research unit UMR 145 jointly involving the IRD and the University of Montpellier 1, showed the chimpanzee subspecies living in the Congo Basin (2) to be the reservoir of HIV-1 virus group M, the source of the world pandemic and that of another, very rare variant, HIV-1 group N. However, the reservoir of the third HIV-1 group, group O which infects humans (3), remained unidentified up to now.

This team announces, in an article in the journal Nature, the discovery of a simian immunodeficiency virus (SIV) infection in wild gorillas. Samples of faeces collected from different communities of gorillas found in the remotest areas of the Cameroon tropical forest were found to contain antibodies against this virus, called SIVgor. The genetic characteristics of the virus were present again in three gorillas living more than 400 km apart. Phylogenetic analysis of SIVgor showed it to be related to HIV-1 group O found in humans, essentially in Cameroon and in neighbouring countries.

This discovery of an HIV-1 related virus in wild gorillas does not, however, call into question the fact that chimpanzees are the primary reservoir of SIV/HIV viruses that crop up again in gorillas and in humans. As Martine Peeters of the IRD says, "the viruses of groups M and N are, very clearly, the consequence of inter-species transmission from chimpanzee to humans, whereas the origin of HIV-1 group O is less apparent. It cannot be excluded that chimpanzees infected by HIV-1 group O might have contaminated humans and the gorilla independently, or that the gorilla, having been contaminated by the chimpanzee, might have contaminated humans".

This work thus opens up a Pandora's box on the questions and speculations concerning the ability of these viruses to cross over from one species to another. The main challenges facing these teams for future work will be determination of the prevalence, the geographical distribution and biology of SIV infections in these great apes, not forgetting the question of how the gorillas were contaminated. This last point remains a mystery,considered as rare.

1. UMR 145: Fran Van Heuverswijn, Cecile Neel, Florian Liegeois, Christelle Butel, Eric Delaporte and Martine Peeters jointly involving the IRD and the University of Montpellier1 University of Alabama (Beatrice Hahn and her colleagues), University of Nottingham (Paul Sharp and his colleagues) PRESICA Project of Cameroon headed by Eitel Mpoudi-Ngole.

2. Keele BF, Van Heuverswyn F, Li Y, Bailes E, Takehisa J, Santiago ML, Bibollet-Ruche F, Chen Y, Wain LV, Liegeois F, Loul S, Mpoudi Ngole E, Bienvenue Y, Delaporte E, Brookfield JF, Sharp PM, Shaw GM, Peeters M, Hahn BH. Chimpanzee Reservoirs of Pandemic and Nonpandemic HIV-1. Science. 2006 , 313 : 523-6

3. Scientists have known for a long time that the Aids virus shows a very strong genetic variability. Two main types of the virus exist: HIV 1 and HIV 2. HIV 1, the most widely spread in the world, embraces three groups (M, N,O) which manifest different genetic characteristics. Within group M, the most frequent, still 9 further subtypes can be distinguished (A, B, C, D, F, G, H, J, K), genetically close yet distinct.

Institut de Recherche Pour le Développement


Related Hiv-1 Current Events and Hiv-1 News Articles


Cell-associated HIV mucosal transmission: The neglected pathway
Dr. Deborah Anderson from Boston University School of Medicine (BUSM) and her colleagues are challenging dogma about the transmission of the human immunodeficiency virus type 1 (HIV-1).

Narrow time window exists to start HIV therapy, study shows
HIV-1-infected U.S. military members and beneficiaries treated with antiretroviral therapy (ART) soon after infection were half as likely to develop AIDS and were more likely to reconstitute their immune-fighting CD4+ T-cells to normal levels, researchers reported Nov. 24 in JAMA Internal Medicine.

New study reveals why some people may be immune to HIV-1
Doctors have long been mystified as to why HIV-1 rapidly sickens some individuals, while in others the virus has difficulties gaining a foothold.

Can HIV be transmitted via manicure instruments?
The Centers for Disease Control and Prevention (CDC) lists numerous potential alternative sources of HIV transmission in addition to the known classical modes for acquiring the AIDS virus.

A new dent in HIV-1's armor
Like a slumbering dragon, HIV can lay dormant in a person's cells for years, evading medical treatments only to wake up and strike at a later time, quickly replicating itself and destroying the immune system.

Researchers turn computers into powerful allies in the fight against AIDS
The battle against AIDS cannot be won in the laboratory alone. To fight the potentially deadly virus that 34 million people are suffering from we need help from computers. Now research fron University of Southern Denmark turns computers into powerful allies in the battle.

HIV pandemic's origins located
The HIV pandemic with us today is almost certain to have begun its global spread from Kinshasa, the capital of the Democratic Republic of the Congo (DRC), according to a new study.

Longstanding bottleneck in crystal structure prediction solved
Two years after its release, the HIV-1 drug Ritonavir was pulled from the market. Scientists discovered that the drug had crystallized into a slightly different form-called a polymorph-that was less soluble and made it ineffective as a treatment.

Antibodies, together with viral 'inducers,' found to control HIV in mice
Although HIV can now be effectively suppressed using anti-retroviral drugs, it still comes surging back the moment the flow of drugs is stopped. Latent reservoirs of HIV-infected cells, invisible to the body's immune system and unreachable by pharmaceuticals, ensure that the infection will rebound after therapy is terminated.

New research offers hope for HIV vaccine development
In a scientific discovery that has significant implications for HIV vaccine development, collaborators at the Boston University School of Medicine (BUSM) and Duke University School of Medicine have uncovered novel properties of special HIV antibodies.
More Hiv-1 Current Events and Hiv-1 News Articles

HIV Won't Kill Me: Encouragement eBook (Josh Fights HIV Stigma 1)

HIV Won't Kill Me: Encouragement eBook (Josh Fights HIV Stigma 1)
by imstilljosh.com


Learning you are HIV-positive is a pretty scary time in a person's life. Josh Robbins found out that he was living with HIV in the beginning of 2012 and started an online journey encouraging others that are living with the virus to keep their mind and spirit in a good place. His main method of offering that encouragement? By sharing images. This coffee-table formatted book shares the images that Josh Robbins of imstilljosh.com uses to fight HIV stigma.

The First Year: HIV: An Essential Guide for the Newly Diagnosed

The First Year: HIV: An Essential Guide for the Newly Diagnosed
by Brett Grodeck (Author), M.D. Daniel S. Berger M.D. (Foreword)


This supportive resource explores the next generation of HIV/AIDS drugs and also includes new research on HIV and crystal meth, as well as new insights for the hardest hit population — African Americans.

One Family's AIDS

One Family's AIDS
by Sweet Georgia Press


One Family’s AIDS is the story of Gene Alexander McCoy - a young, educated African-American man who finds himself in a race for time to make peace with his family and God upon being diagnosed with HIV. The story, told from four different perspectives, chronicles Gene's life as he confronts such issues as HIV/AIDS, family, abandonment and homophobia. With the help of his over-bearing mother, a nurturing grandmother, and an uncle who doesn't feel comfortable talking about Gene's sexuality or disease, we learn the complexities of love and relationships, the damaging results of fear and shame, and how the relentless quest for the truth ultimately leads us back to each other.

HIV-1 Integrase: Mechanism and Inhibitor Design

HIV-1 Integrase: Mechanism and Inhibitor Design
by Nouri Neamati (Editor), Binghe Wang (Editor)


This book comprehensively covers the mechanisms of action and inhibitor design for HIV-1 integrase. It serves as a resource for scientists facing challenging drug design issues and researchers in antiviral drug discovery. Despite numerous review articles and isolated book chapters dealing with HIV-1 integrase, there has not been a single source for those working to devise anti-AIDS drugs against this promising target. But this book fills that gap and offers a valuable introduction to the field for the interdisciplinary scientists who will need to work together to design drugs that target HIV-1 integrase.

HIV-1: Molecular Biology and Pathogenesis: Viral Mechanisms, 2nd Edition (Advances in Pharmacology, Vol. 55)

HIV-1: Molecular Biology and Pathogenesis: Viral Mechanisms, 2nd Edition (Advances in Pharmacology, Vol. 55)
by Kuan-Teh Jeang (Editor), J. Thomas August (Editor), Ferid Murad (Editor)


This volume covers the latest advances in the mechanisms of pathogenesis of the HIV-1 virus on target cells. Its companion volume, Advances in Pharmacology 56, shows how new developments in understanding the virus translate to the clinical setting.

From Fear to Hope: the story of the early years of the Terrence Higgins Trust, the UK's first HIV/AIDS charity

From Fear to Hope: the story of the early years of the Terrence Higgins Trust, the UK's first HIV/AIDS charity
by Martin Hoskins


The Terrence Higgins Trust was formed in November 1982 by some of his close friends. Terry Higgins, was not first person to die from an AIDS-related illness in Britain, although he was the first to be publicly identified.
This book charts the first 15 years of that organisation, as it transformed itself from a volunteer led charity to a more professionally run organisation. Within years of its establishment, the Trust was experiencing massive growth. Large numbers of people were becoming HIV positive and, with the introduction of AZT, the first effective drug treatment against HIV, clients were generally not dying as quickly as before. This created further demands in terms of counselling and support, as well as the need for more campaigns to warn people of the possible dangers to...

Too Much of One Thing

Too Much of One Thing
by The Write to Inspire


Faith Carter thinks she is living the high life in California, getting any man she wants. However she soon finds out living in the fast line is not all that it’s cracked up to be. Will she survive a life changing situation?

This is a short-story from the Sweet-Bites range published under The Write to Inspire Publishing Company.

HIV Essentials 2014

HIV Essentials 2014
by Paul E. Sax (Author), Calvin J. Cohen (Author), Daniel R. Kuritzkes (Author)


The world's leading experts provide all the 'essentials' needed to manage HIV patients in the office, on the ward, and in the ICU. Completely revised and updated, HIV Essentials 2014 incorporates the latest clinical guidelines into a step-by-step guide to the diagnosis, evaluation, management, and prevention of HIV infection and its complications. Topics include: opportunistic infections and other HIV complications, treatment of HIV and pregnancy, antiretroviral drug summaries, post-exposure prophylaxis, as well as commercially available dosage forms for all ARVs.

First Aid Q&A for the USMLE Step 1, Third Edition (First Aid USMLE)

First Aid Q&A for the USMLE Step 1, Third Edition (First Aid USMLE)
by Tao Le (Author), James A. Feinstein (Author), Mark W. Ball (Author), Annie Dude (Author), Rebecca L. Hoffman (Author), Mark Robert Jensen (Author), Kimberly Kallianos (Author), Cesar Raudel Padilla (Author), Lauren Rothkopf (Author), James Yeh (Author)


1,000 questions and answers prepare you for the USMLE Step 1! The only comprehensive Q&A review for the USMLE Step directly linked to high-yield facts from Dr. Le's First Aid for the USMLE Step 1, this essential study guide offers 1000 board-style questions and answers, easy-to-navigate, high yield explanations for correct and incorrect answers, and more than 350 accompanying images. Features:
1000 board-style questions and answers -- reviewed and approved -- by students who just aced the exam Detailed explanations for both right and wrong answers - with letter options in boldface for at-a-glance review Chapters keyed to Dr. Le's First Aid for the USMLE Step 1 so you can simultaneously review questions and high-yield facts 130+ high-yield images, diagrams, and tables One...

© 2014 BrightSurf.com